BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26205959)

  • 21. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies.
    Taha M; Ismail NH; Lalani S; Fatmi MQ; Atia-Tul-Wahab ; Siddiqui S; Khan KM; Imran S; Choudhary MI
    Eur J Med Chem; 2015 Mar; 92():387-400. PubMed ID: 25585009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
    Dhameja M; Gupta P
    Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent synthesis of new α-glucosidase inhibitors obtained through a vinyl Grignard-mediated carbocyclisation.
    Knudsen IMB; Hedberg C; Ladefoged LK; Ide D; Brinkø A; Eikeland EZ; Kato A; Jensen HH
    Org Biomol Chem; 2018 Aug; 16(34):6250-6261. PubMed ID: 30110037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new α-glucosidase inhibitors based on oleanolic acid incorporating cinnamic amides.
    Nie W; Luo JG; Wang XB; Yin H; Sun HB; Yao HQ; Kong LY
    Chem Pharm Bull (Tokyo); 2011; 59(8):1051-6. PubMed ID: 21804254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
    Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
    Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Glucosidase enzyme inhibitory effects and ursolic and oleanolic acid contents of fourteen Anatolian Salvia species.
    Kalaycıoğlu Z; Uzaşçı S; Dirmenci T; Erim FB
    J Pharm Biomed Anal; 2018 Jun; 155():284-287. PubMed ID: 29677678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of thiobarbituric acid derivatives: In vitro α-glucosidase inhibition and molecular docking studies.
    Barakat A; Ali M; Mohammed Al-Majid A; Yousuf S; Iqbal Choudhary M; Khalil R; Ul-Haq Z
    Bioorg Chem; 2017 Dec; 75():99-105. PubMed ID: 28926784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
    Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
    Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new functionality study of vanillin as the inhibitor for α-glucosidase and its inhibition kinetic mechanism.
    Liu Y; Zhu J; Yu J; Chen X; Zhang S; Cai Y; Li L
    Food Chem; 2021 Aug; 353():129448. PubMed ID: 33711702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
    Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
    Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
    Wang G; Peng Z; Gong Z; Li Y
    Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
    Özil M; Emirik M; Beldüz A; Ülker S
    Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
    Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition mechanism of ferulic acid against α-amylase and α-glucosidase.
    Zheng Y; Tian J; Yang W; Chen S; Liu D; Fang H; Zhang H; Ye X
    Food Chem; 2020 Jul; 317():126346. PubMed ID: 32070843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel series of mixed-ligand M(II) complexes containing 2,2'-bipyridyl as potent α-glucosidase inhibitor: synthesis, crystal structure, DFT calculations, and molecular docking.
    Avcı D; Altürk S; Sönmez F; Tamer Ö; Başoğlu A; Atalay Y; Zengin Kurt B; Dege N
    J Biol Inorg Chem; 2019 Aug; 24(5):747-764. PubMed ID: 31317269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional α-glucosidase inhibitors from Malbranchea flavorosea (Leotiomycetes, Ascomycota).
    Rebollar-Ramos D; Macías-Ruvalcaba ML; Figueroa M; Raja HA; González-Andrade M; Mata R
    J Antibiot (Tokyo); 2018 Oct; 71(10):862-871. PubMed ID: 30018423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.